Apellis Pharmaceuticals, Inc. (APLS)
22.06
-0.40
(-1.80%)
USD |
NASDAQ |
Feb 24, 16:00
22.06
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap : 2.792B for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amneal Pharmaceuticals, Inc. | 4.612B |
| Alnylam Pharmaceuticals, Inc. | 44.11B |
| Amicus Therapeutics, Inc. | 4.503B |
| Ionis Pharmaceuticals, Inc. | 13.84B |
| Sarepta Therapeutics, Inc. | 1.975B |
Market Cap Related Metrics
| PE Ratio | 74.29 |
| PS Ratio | 2.747 |
| Price to Book Value | 6.959 |
| Price to Free Cash Flow | 35.50 |
| Price | 22.06 |
| Earnings Yield | 1.35% |
| Operating PE Ratio | 34.72 |
| Normalized PE Ratio | 74.32 |